When and how use pralidoxime injection in OP poisoning?
Reading File
Finding Sources
Searching PubMed
pralidoxime organophosphate poisoning
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
I have comprehensive information from multiple authoritative sources. Let me now compile the complete answer.
Pralidoxime (2-PAM) in Organophosphate (OP) Poisoning
Mechanism of Action
Pralidoxime (2-PAM, Protopam) is a cholinesterase reactivator - an oxime that works by:
- Competing for the phosphate moiety of the OP compound and releasing it from the inhibited acetylcholinesterase (AChE) enzyme - effectively dephosphorylating the inactivated enzyme
- Reactivating AChE at the neuromuscular junction (nicotinic sites) - this is its primary advantage over atropine
- Preventing phosphorylated enzyme formation ("aging")
- Directly detoxifying some organophosphate compounds
- It contains a quaternary nitrogen that binds to the choline-binding site of AChE, positioning the oxime group to attack the phosphate bond
Critically: pralidoxime does not cross the blood-brain barrier (BBB), so it does not reverse CNS effects. It is most effective at nicotinic (neuromuscular) sites, which atropine cannot reverse. - Tintinalli's Emergency Medicine
When to Use (Indications)
- All cases of moderate to severe OP poisoning where muscular paralysis, respiratory failure, or fasciculations are present
- To be given as early as possible - the earlier, the better, before "aging" of the phosphorylated enzyme complex occurs
- Can still be beneficial when given 24-48 hours after exposure, since aging kinetics vary by compound
- In severe poisoning, multiple doses over several days may remain useful even late
- Give whenever OP poisoning is suspected - do not wait for lab confirmation of cholinesterase levels
- Also indicated for nerve agent exposures (sarin, VX)
"Pralidoxime reverses muscle paralysis if given early, before aging occurs... pralidoxime be administered as soon as possible before permanent and irreversible [enzyme inactivation]." - Tintinalli's Emergency Medicine
Dosing (Adults)
| Parameter | Dose |
|---|---|
| Loading dose | 1-2 g IV (30 mg/kg, max 2 g) as a 5% solution over 5-30 minutes |
| Infusion rate | Not faster than 200 mg/min (to avoid neuromuscular blockade) |
| Maintenance infusion | 8-10 mg/kg/hour (Rosen's); or 0.5 g/hour as 2.5% infusion |
| Repeat bolus | Can repeat in 1 hour if muscle weakness/fasciculations persist |
| Duration | Repeat every 6-12 hours for 24-48 hours; continue until patient is clinically well and no longer requires atropine |
| Maximum | Do not exceed 12 g in 24 hours |
Pediatric dose: 25-50 mg/kg IV; or 30 mg/kg (up to 1 g) over 5-10 minutes, followed by infusion at 8 mg/kg/hour. - Tintinalli's / Rosen's / Parikh's Forensic Medicine
How to Administer
- Mix with normal saline and infuse IV (do not give rapid IV push - risk of neuromuscular weakness, tachycardia, laryngospasm)
- Give together with atropine - they work synergistically
- Pralidoxime decreases the total amount of atropine required and potentiates atropine's action
- Continue until the patient is clinically stable, off atropine, and showing no signs of cholinergic toxicity
Key Points on Timing: "Aging"
The enzyme-phosphate complex undergoes a process called aging (irreversible conformational change), after which oximes are ineffective. The speed of aging depends on the specific compound:
| Compound | Aging time |
|---|---|
| Soman (GD) | Minutes (very rapid - oximes may be too late) |
| Sarin (GB) | ~5 hours |
| Tabun (GA) | ~14 hours |
| Most pesticide OPs | 24-48+ hours |
This is why pralidoxime should be started immediately and before blood results are back.
Compounds Where Oximes Are Ineffective/Less Effective
Pralidoxime has limited or no benefit against:
- Dimefox, dimethoate, ciodrin, methyl diazinon, methyl phenocapton, phorate, schradan, wepsyn
Contraindications / Cautions
- Carbamate poisoning (single-agent carbaryl): pralidoxime is contraindicated - may potentiate toxicity. However, if the agent is uncertain (mixed OP/carbamate exposure) or carbamates like aldicarb/methomyl are involved, it can still be considered
- Excessive doses of pralidoxime itself can cause neuromuscular weakness
- Avoid rapid IV bolus (can cause laryngospasm, tachycardia, hypertension)
Comparison with Atropine
| Feature | Atropine | Pralidoxime |
|---|---|---|
| Site of action | Muscarinic receptors | Nicotinic (NMJ) + enzyme reactivation |
| Reverses bronchospasm/secretions | Yes | No |
| Reverses muscle paralysis | No | Yes (if given early) |
| CNS penetration | Yes | No |
| Used alone if needed? | Yes | No - always combine with atropine |
Alternative Oximes
- Obidoxime chloride: more potent but slightly more toxic; dose 250 mg IV or IM - can substitute if pralidoxime unavailable
- DAM (diacetyl monoxime): does cross the BBB, can regenerate some CNS cholinesterase; used in some settings
Recent evidence note: A 2025 meta-analysis (PMID 40714568) on adjunctive therapies in OP poisoning and a 2025 systematic review (PMID 40792609) on magnesium sulfate as co-adjuvant are recent. Notably, the efficacy of pralidoxime has been debated in some large trials (the SRI Lanka POET trial found no mortality benefit), but current consensus still recommends its use, particularly early in severe cases with respiratory muscle paralysis.
Sources: Tintinalli's Emergency Medicine, Rosen's Emergency Medicine, Parikh's Forensic Medicine & Toxicology, The Essentials of Forensic Medicine and Toxicology (2026), Katzung's Basic & Clinical Pharmacology, Lippincott Illustrated Reviews: Pharmacology
This is a shared conversation. Sign in to Orris to start your own chat.